New report celebrates a decade of progress in chronic diseases
By Holly Campbell | February 25, 2016
In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...
Read More
Burden on Patients: 5 Questions on access to multiple sclerosis medicines in health exchange plans
By Allyson Funk | December 4, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to...
Read More
New PhRMA and Epilepsy Foundation Report: 420 Medicines in Development for Neurological Disorders
By Tina Stow | July 13, 2015
It’s hard to imagine, but there are currently more than 50 million Americans – nearly one-sixth of our population – affected by some type of neurological disorder. While some of these are more...
Read More
New Evidence of Discrimination in Essential Health Benefit Plans
By Tina Stow | January 30, 2015
While the Affordable Care Act (ACA) expanded access to health insurance coverage for millions, a new study from the Harvard T.H. Chan School of Public Health reveals that insurers may be...
Read More
Burden on Patients: One-Size-Fits-All Approach to Treating Multiple Sclerosis Hurts Patients
By Allyson Funk | July 2, 2014
Recently, we discussed the obstacles patients face in managing chronic conditions such as mental health disorders, HIV/AIDS and Rheumatoid Arthritis under the Affordable Care Act’s health...
Read More
Medicare Monday (100)
340B Spotlight (36)
Cost & Consequence (0)
